Conferences Mind conferences are accredited with Continuing Professional Development (CPD) and Continuing Education (CE), Continuing Medical Education (CME) credits respectively. This is the best platform of the worldwide Conferences, Symposia, Workshops and Exhibitions, include all major science (Medical, Clinical, Pharma, Life Science), Technology (Robotics, Mechatronics), Business Management and Engineering.
image description

Welcome To
Global Conference on

Covid 19

THEME: Covid-19 Fighting with Invisible Virus

WEBINAR: International Web Conference       August 20-22, 2020

CONFERENCE: Update Soon.....        USA
Download Brochure Submit Abstract Registration OCM

Global Conference On Covid-19’’ which is scheduled during August 20-22, 2020. Most Countries around the World have faced cases of COVID-19 and many are experiencing outbreaks. However, the situation is unpredictable therefore Global Covid-19 2020 team  welcomes everyone worldwide to be a part of WEBINAR: International Web Conference. This International Web Conference provides an E-learning opportunity and to contribute your big Idea to shape the future for achieving better health for all, We request you all to  showcase you recent research and advancement in the field of Covid-19(Corona Virus) as a Global Respond. This Web Conference gives a forum to interactive and encourages a level of discussion about the recent pandemic Covid -19 Virus. This is the best Web platform to showcase Your’s recent research innovations which will reach millions of health workers and others worldwide through International Web Conference and gain new information which is able to be valuable for growth within the field of generating new plans and ideas to reinforce yourself and your skilled profession. Global Covid-19 2020 Conference focused on the theme: “Covid-19 Fighting with Invisible Virus”.

Read more

Track 1. Covid-19 (Corona Virus):

'CO' stands for corona, 'VI' for virus, and 'D' for disease. The COVID-19 virus spreads principally through droplets of saliva or discharge from the nostril when an infected individual coughs or sneezes, Coronaviruses are a group of viruses that are recognized to cause sickness ranging from the frequent cold to greater extreme diseases such as Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS). The exceptional way to stop and sluggish down transmission is to guard yourself and others from contamination through washing your palms or the usage of an alcohol based totally rub often and no longer touching your face.

Track 2. SARS-CoV-2:

SARS-CoV-2 is a coronavirus that causes coronavirus disease (COVID-19). SARS-CoV-2 mainly seems to travel from person to person. However, some questions about its transmission remain unanswered. According to their specific characteristics, there are four main ranks, or genera, of coronavirus: alpha, beta, delta, and gamma. Most of only affect animals, but a few can also pass to humans. Those that are transmissible to humans belong to only two of these genera: alpha and beta.

Track 3. Medical education: COVID ?19 and surgery:

The COVID?19 pandemic will continue to have a major impact on surgical practice, with guidance within hospitals needed urgently. There is a clear need for social distancing, and this is the most effective mitigative measure until a vaccine or antiviral medication is found. As such, much of teaching has already transitioned to an online platform. However, surgery is an art that can only be perfected in the operating theatre. Learning about the various instruments involved, the roles of the multidisciplinary team, and the steps that clinicians take throughout the patient journey to ensure patient safety, is best experienced. It may well be time to reform the medium of delivering surgical education.

Track 4. Covid-19 impact on Gynecological Cancers:

Abdominal pain is also part of the symptom complex of most gynecological cancers, especially uterus and ovary, switching these patients to open surgery will likely worsen surgical outcomes and increase potential exposure to COVID?19 in the postoperative period. Cancer guidelines are being modified and prioritized due to the restrictions imposed. Minimally invasive surgery (either laparoscopic or robotic) is associated with reduced length of stay, reduced need for intensive care support, reduced blood loss and enhanced recovery. Surgeons are currently in the midst of a delicate balancing act of protecting our patients from COVID?19 and providing timely treatment of their cancer.

Track 5. Identifying Potential Risks and Sources of Exposure:

In assessing potential hazards, employers should consider if and when their workers may encounter someone infected with SARS-CoV-2 in the course of their duties. Employers should also determine if workers could be exposed to environments (e.g., work sites) or materials (e.g., laboratory samples, waste) contaminated with the virus. Depending on the work setting, employers may also rely on the identification of sick individuals who have signs, symptoms, and/or a history of travel to COVID-19 affected areas, to assist pick out publicity dangers for people and put in force suitable manage measures.

Track 6. Solid Waste and Wastewater Management general interim guidance to increased risk of occupational exposure to SARS-CoV-2 :

Municipal Waste:

Workers and employers ought to control municipal (e.g., household, business) solid waste with doable or recognized SARS-CoV-2 illness like any different non-contaminated municipal waste. Use regular engineering and administrative controls, protected work practices, and PPE, such as puncture-resistant gloves and face and eye protection, to stop employee exposure to the waste streams (or kinds of wastes), along with any contaminants in the materials, they manage.

Medical Waste:

Medical waste with doable or regarded COVID-19 contamination, control like any different regulated clinical waste. COVID-19 is now not a Category A infectious substance. For regulated clinical waste information, seek advice from the regulated clinical waste information in CDC's Guidelines for Environmental Infection Control in Health-Care Facilities. This record gives extra data associated to the administration of waste streams from hospitals and different healthcare facilities.


Coronaviruses are prone to the identical disinfection conditions in the healthcare placing as different viruses, so present-day disinfection prerequisites in wastewater cure facilities are predicted to be sufficient. This consists of stipulations for practices such as oxidation with hypochlorite (i.e., chlorine bleach) and peracetic acid, as nicely as inactivation through the use of ultraviolet irradiation. There is no proof to advise that additional, COVID-19 specific protections are wished for personnel worried in wastewater administration operations, inclusive of these at wastewater cure facilities. Wastewater therapy plant operations have to make certain people observe hobbies practices to forestall exposure to wastewater, which includes the usage of the engineering and administrative controls, safe work practices, and required for work duties when dealing with untreated wastewater.

Track 7. COVID-19 Treatment:

Till now no vaccine or specific treatment for COVID-19 is available. Hospitals can provide supportive care for people who have serious cases of COVID-19. Anyone can become infected with SARS-CoV-19, however, those with a higher risk of severe illness should exercise additional caution. People who have serious underlying medical conditions, such as heart or lung disease or diabetes, may be at increased risk of complications from COVID-19.

Safety Guidance:

  •  Frequently Wash your hands with soap and water for 20 seconds. When soap and running water are unavailable, use an alcohol-based hand rub with at least 60% alcohol.
  • Avoid touching your body areas like eyes, nose, or mouth with unwashed hands, Practice good respiratory etiquette, including covering coughs and sneezes.
  • Maintain distance with people who are sick and Stay home if you are sick.
  • Certain people, including older adults and those with underlying conditions such as heart or lung disease or diabetes, are at higher risk for developing more serious complications from COVID-19.


Track 8. R&D Blueprint (COVID-19):

The R&D Blueprint works on the basis of a listing of identified precedence diseases. These are diseases that pose a public health risk due to the fact of their epidemic viable and for which there are no, or insufficient, countermeasures. R&D Blueprint is an international method and preparedness plan that permits the rapid activation of R&D things to do at some point of epidemics. Its aims are to fast-track the availability of high-quality tests, vaccines and drug treatments that can be used to save lives and avoid massive scale crisis. R&D Blueprint has been activated to speed up diagnostics , vaccines and therapeutics for this novel coronavirus (COVID-19).

Track 9. SARS-CoV-2 Compare with Other Coronaviruses:

Just like there are different kinds of related viruses that cause smallpox, chickenpox, and monkeypox, specific coronaviruses cause extraordinary illnesses in people. The Severe Acute Respiratory Syndrome (SARS) coronavirus causes SARS and the Middle East Respiratory Syndrome (MERS) coronavirus causes MERS. The novel coronavirus accountable for the contemporary pandemic, SARS-CoV-2, is one of seven types of recognized human coronaviruses. SARS-CoV-2, like the MERS and SARS coronaviruses, likely developed from a virus until now found in animals. The final known coronaviruses cause a significant proportion of colds in adults and children, and these are no longer a serious threat for otherwise healthy adults.

Track 10. Covid-19 pandemic impact on Anti-Microbial Resistance (AMR):

In addition to the direct impact on Anti-Microbial Resistance (AMR) as an end result of improved antibiotic use, the transmission of AMR beyond the clinical machine have to be viewed and assessed. One simple instance is release of increased level of antimicrobials in waste water from health center system that will have an effect on level of antimicrobials in the environment, which will impact the level of resistance in each animal (both wildlife and feed animals) and in farming and natural systems. AMR will possibly increase through the heavy use of antibiotics in Covid-19 affected person treatment. New and extended functional therapeutics, which includes antibiotics and antibiotic combinations, alternative remedies to antibiotic use, and the predictive prevention of bacterial respiratory infections using vaccines should be investigated in the context of Covid-19.

Read more

  • Track 1 : Covid-19 (Corona Virus)
  • Track 2 : SARS-CoV-2
  • Track 3 : Medical education: COVID ?19 and surgery
  • Track 4 : Covid-19 impact on Gynecological Cancers
  • Track 5 : Identifying Potential Risks and Sources of Exposure
  • Track 6 : Solid Waste and Wastewater Management general interim guidance to increased risk of occupational exposure to SARS-CoV-2
  • Track 7 : COVID-19 Treatment
  • Track 8 : R&D Blueprint (COVID-19)
  • Track 9 : SARS-CoV-2 Compare with Other Coronaviruses
  • Track 10 : Covid-19 pandemic impact on Anti-Microbial Resistance (AMR)

Read more

Organizing Committee



Media Partners And Collaborators

Talk To Us

Speak directly to one of our conference representatives by calling.
+91 7735912022

Mail Us

E-mail us your questions about the conference. We will respond to your questions.
Sponsors / Exhibiting / Advertising

Contact Us